Biotechnology News

Hummingbird Bioscience appoints Dr. James Garner as President. Dr. Garner will join the leadership team and work alongside Piers Ingram, CEO.

Company announcement no. 35 - 2615 September 2026 Transactions in connection with share buy-back program On 4 March 2026 NTG Nordic Transport Group (“NTG”) announced a share buy-back program, as...

MELBOURNE, Australia, Sept. 15, 2026 (GLOBE NEWSWIRE) -- ENA Respiratory, a clinical-stage pharmaceutical company developing host defence enhancers for the prevention of complications associated...

A potent and selective PAD4 inhibitor demonstrates efficacy comparable to an anti-TNFα biologic in a mouse model of arthritis 15 September 2026 – C4X Discovery Holdings Ltd ("C4XD"), a pioneering...

One04 Therapeutics launches on encouraging CPV-104 Phase 1 interim results and plans to expand clinical development to include kidney diseases and dry AMD

Eleva separates Bryotechnology platform and clinical-stage Factor H biotherapeutic into independent companies

LOUISVILLE, Colo., Sept. 14, 2026 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostics solutions company, today announced that Brianna Phillips, Vice President of Quality and...

CARSON CITY, Nev., Sept. 14, 2026 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) ("BioVie" or the "Company"), a clinical-stage company developing innovative drug therapies for neurological and...

GENFIT Advances Nangibotide in Phase 2 Clinical Investigation in ACLF

L’acquisition par GENFIT du nangibotide, un candidat-médicament au profil différencié en phase avancée de développement clinique, renforce le portefeuille de thérapies innovantes de la Société...